Skip to main content
OpenTrials
Completed

NCT Number: NCT07137611

Effects of Different Types of Exercise on BDNF and Cognitive Performance (Exercise-BDNF)

Purpose The purpose of this study is to determine the acute effects of different exercise intensities (low, moderate, high) on brain-derived neurotrophic factor (BDNF) levels, trail making test performance, and perceived sensation scale.

Method

This randomized crossover controlled trial aimes to examine the acute effects of four experimental conditions-high-intensity interval training (HIIT), moderate-intensity continuous training (MICT), low-intensity continuous training (LICT), and a resting control (CTRL)-on cognitive performance (via the Stroop test, targeting executive function) and associated neurochemical responses (e.g., serum BDNF and blood lactate levels) in healthy young adults aged 18-25 years.

All participants will complete the four conditions in a randomized and counterbalanced manner. To ensure balanced exposure, they were assigned to one of four groups (n = 3 per group), each following a distinct condition order based on a Latin square design. This approach guaranteed that each session occurred equally across time points (sessions 1-4) and that the order minimized sequence effects by rotating the position of each condition relative to the others.

To control for potential carryover-particularly from elevated neurochemical responses following intense exercise (BDNF increases reported -no two high-intensity sessions will be scheduled consecutively. Where possible, higher and lower intensity protocols will be alternated. Furthermore, a seven-day interval separated each session to reduce residual physiological or cognitive effects.

The trial protocol was developed in line with CONSORT and SPIRIT guidelines, including relevant extensions for within-subject designs and non-pharmacological interventions. Participants were blinded to the study hypothesis (Pandis et al., 2017; Hopewell et al., 2025).

All exercise sessions will be conducted under supervision of a certified strength and conditioning coach to ensure consistency and adherence to protocol. in the morning (09:00-11:00) on a track and field pitch to control for chronobiological variation. Participants were instructed to avoid strenuous activity for 48 hours prior, abstain from alcohol and caffeine for 24 hours, and obtain at least 7-8 hours of sleep before each session. Dietary habits and general lifestyle were to remain unchanged throughout the study.

During the first visit, participants' body weight and body fat percentage were assessed using bioelectrical impedance analysis. Resting heart rate was then recorded, followed by administration of the Yo-Yo Intermittent Recovery Test Level 1 to determine maximal aerobic speed, aerobic capacity, and peak heart rate.

In the following four visits, each participant completed all experimental conditions. Each exercise session will begin with a standardized 10-minute warm-up, including light jogging, dynamic stretching, and movement preparation drills.

All exercise sessions were conducted on a standard track and field facility and lasted 40 minutes in total, consisting of a 10-minute standardized warm-up, 24 minutes of exercise, and a 5-minute recovery period. The exercise component was individually prescribed based on each participant's maximal aerobic speed, determined from the Yo-Yo Intermittent Recovery Test Level 1. All running distances were calculated individually using time × speed formulas based on each participant's maximal aerobic speed, ensuring workload equivalence across conditions.

* High-Intensity Interval Training: Participants ran at 110% of their MAS for 15-second intervals. * Moderate-Intensity Continuous Training: Participants ran at a speed corresponding to 70-80% of their MAS. * Low-Intensity Continuous Training: Participants ran continuously for 24 minutes at 50-60% of their MAS without breaks. * Control: Participants remained seated at rest for the same duration (40 minutes), under the same environmental conditions and time schedule as the active conditions.

Venous blood samples were collected before and immediately after each session to assess neurochemical markers. Subsequently, cognitive performance was evaluated using the computerized Stroop test to measure executive function. Heart rate was continuously monitored during all exercise conditions using a Polar V800 device. Following each session, psychophysiological responses were assessed using the Rating of Perceived Exertion scale and the Exercise Enjoyment Scale.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–25 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Aksaray University

Aksaray, Center, 68000, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged between 18 and 25 years
  • No known medical condition that prevents participation in exercise
  • Not currently using any pharmacological agents
  • Exclusion Criteria:
  • Experiencing any discomfort before, during, or after exercise
  • Current or past diagnosis of pharmacological or doping substance use
  • Engaging in regular exercise (more than 3 times per week) within the last 2 weeks
  • History of alcohol or substance addiction
  • Any other condition or factor that may prevent full participation in the study protocol

Treatment and study plan

Low Exercise

Behavioral
  • Low-Intensity Continuous Training (LICT): Participants will run continuously for 24 minutes at 50-60% of their MAS without breaks.

Other names: Low Intensity Exercise

Moderate-Intensity Exercise

Behavioral

Moderate-Intensity Continuous Training (MICT): Participants will run at a speed corresponding to 70-80% of their MAS. The protocol consists of four 4-minute bouts, separated by 2-minute active recovery periods, during which participants performed light jogging. This pattern totaled 24 minutes of exercise.

Other names: Moderate Intensity Exercise

HIIT exercise

Behavioral

High-Intensity Interval Training (HIIT): Participants will run at 110% of their MAS for 15-second intervals, covering a pre-calculated distance during each bout. After each 15-second sprint, they will rest passively for 15 seconds and returned to their starting point. This will be repeated continuously for 3 minutes, constituting one set. A total of four 3-minute sets will be completed, interspersed with 3-minute passive rest periods, yielding a total exercise time of 24 minutes.

Primary outcomes

  1. BDNF

    Time frame: Baseline and immediately after exercise (Day 1)

    BDNF will be measured using a Sunred brand ELISA kit from blood samples taken baseline and after exercise, and the results will be reported in pg/mL units.

  2. Lactate

    Time frame: Baseline and immediately after exercise (Day 1)

    Lactate levels will be measured in millimoles per liter (mmol/L) from capillary/venous blood samples taken before and after exercise using a lactate analyzer.

  3. Rating of Perceived Exertion Scale

    Time frame: Baseline and immediately after exercise (Day 1)

    Rating of Perceived Exertion (RPE) will be scored on the Borg 6-20 scale, where 6 indicates "no exertion" and 20 indicates "maximal exertion." Higher scores reflect greater perceived effort.

  4. Exercise Enjoyment Scale

    Time frame: Baseline and immediately after exercise (Day 1)

    This outcome measures the participant's subjective enjoyment of the exercise session. Participants are asked to rate how much they enjoyed the exercise immediately after completion using a 7-point Likert scale ranging from 1 ("not enjoyable at all") to 7 ("extremely enjoyable"). The scale captures affective responses to physical activity, which can provide insight into adherence, motivation, and overall exercise experience.

Sponsors and collaborators

Lead sponsor

Aksaray University Training and Research Hospital

Other

Registry information

Official study title

Effect of Exercise Intensity on Neurochemical and Cognitive Function: The Role of Lactate and BDNF

Acronym: Exercise-BDNF

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Aug 22, 2025
Registry last updated
Jan 30, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.